Atlas Trials

Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC(ARMOR2501)

Clinical trial NCT06924398 · RECRUITING

Trial details

NCT number
NCT06924398
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer (NSCLC)
Start date
2025-04-20
Primary completion
2025-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.